Mosunetuzumab-axgb may be better tolerated by older adults with relapsed or refractory follicular lymphoma and patients with poor performance status.
Mallory Norman, PharmD, BCOP
Advertisement
Articles by Mallory Norman, PharmD, BCOP
Importantly, when considering the useof small molecule inhibitors, potential drug interactions must be evaluated.
Advertisement
Latest Updated Articles
Small Molecule Inhibitors for the Treatment of Chronic Lymphocytic LeukemiaPublished: April 16th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Sotatercept Demonstrates Significant Reduction in Morbidity and Mortality Across Broader PAH Risk Groups
2
Integrating Combination Therapies for Type 2 Diabetes and CKD
3
Building a Unified Approach to Cardio Kidney Metabolic Health
4
Evolving Mortality Trends in Heart Failure and Vascular Disease: The Critical Role of Pharmacists in Addressing Cardiovascular Risk
5
